Apyx Research Development vs Depreciation And Amortization Analysis

APYX Stock

USD 1.45 0.01 0.69%

Apyx Medical financial indicator trend analysis is way more than just evaluating Apyx Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apyx Medical is a good investment. Please check the relationship between Apyx Medical Research Development and its Depreciation And Amortization accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Research Development vs Depreciation And Amortization

Research Development vs Depreciation And Amortization Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apyx Medical Research Development account and Depreciation And Amortization. At this time, the significance of the direction appears to have weak relationship.

The correlation between Apyx Medical's Research Development and Depreciation And Amortization is 0.37. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Apyx Medical, assuming nothing else is changed. The correlation between historical values of Apyx Medical's Research Development and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Apyx Medical are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Research Development i.e., Apyx Medical's Research Development and Depreciation And Amortization go up and down completely randomly.

Correlation Coefficient

0.37

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Research Development

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most indicators from Apyx Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 88.8 M in 2024, despite the fact that Tax Provision is likely to grow to (2.2 M).

	2021	2022	2023	2024 (projected)
Interest Expense	10K	15K	2.5M	2.6M
Depreciation And Amortization	903K	890K	692K	736.2K

Interest Expense Depreciation And Amortization

Apyx Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.3	0.57	0.82	0.81	0.32	0.19	-0.6	0.15	0.67	0.82	-0.11	0.42	0.94	0.66	-0.45	-0.05	0.74	0.32	0.11	0.77	0.78	0.5	0.4	1.0	0.71
Short Long Term Debt Total	0.3		0.29	0.38	-0.3	-0.01	-0.4	0.31	-0.7	0.5	0.4	0.11	0.7	0.2	0.21	-0.22	-0.26	-0.03	1.0	0.19	0.33	0.48	0.96	0.31	0.28	0.24
Other Current Liab	0.57	0.29		0.81	0.32	0.13	-0.07	-0.12	-0.42	0.8	0.37	-0.24	0.58	0.36	0.86	-0.23	0.18	0.61	0.32	0.38	0.57	0.82	0.5	0.25	0.58	0.61
Total Current Liabilities	0.82	0.38	0.81		0.53	0.23	0.09	-0.54	-0.27	0.95	0.82	-0.23	0.57	0.66	0.89	-0.31	0.14	0.71	0.4	0.21	0.85	0.88	0.62	0.36	0.83	0.71
Total Stockholder Equity	0.81	-0.3	0.32	0.53		0.33	0.43	-0.77	0.63	0.29	0.55	-0.14	-0.04	0.84	0.45	-0.31	0.06	0.73	-0.29	-0.02	0.52	0.44	-0.1	0.23	0.82	0.54
Property Plant And Equipment Net	0.32	-0.01	0.13	0.23	0.33		0.25	-0.32	0.0	0.26	0.26	0.76	0.28	0.13	0.3	-0.7	-0.75	0.61	0.0	0.71	0.37	0.39	0.07	0.88	0.25	0.31
Current Deferred Revenue	0.19	-0.4	-0.07	0.09	0.43	0.25		-0.51	0.35	0.03	0.15	-0.14	-0.56	0.29	0.0	-0.26	-0.03	0.49	-0.39	-0.27	-0.12	0.14	-0.31	0.06	0.21	-0.02
Net Debt	-0.6	0.31	-0.12	-0.54	-0.77	-0.32	-0.51		-0.46	-0.35	-0.73	0.17	0.08	-0.6	-0.48	0.19	-0.16	-0.6	0.3	0.22	-0.63	-0.32	0.11	-0.18	-0.61	-0.46
Retained Earnings	0.15	-0.7	-0.42	-0.27	0.63	0.0	0.35	-0.46		-0.49	-0.07	-0.1	-0.56	0.34	-0.27	0.08	0.09	0.04	-0.71	-0.36	-0.11	-0.41	-0.68	-0.23	0.16	-0.04
Accounts Payable	0.67	0.5	0.8	0.95	0.29	0.26	0.03	-0.35	-0.49		0.7	-0.13	0.63	0.47	0.82	-0.35	0.04	0.61	0.52	0.34	0.77	0.87	0.71	0.4	0.67	0.6
Cash	0.82	0.4	0.37	0.82	0.55	0.26	0.15	-0.73	-0.07	0.7		-0.12	0.45	0.74	0.65	-0.32	0.03	0.58	0.42	-0.06	0.85	0.69	0.58	0.37	0.82	0.65
Non Current Assets Total	-0.11	0.11	-0.24	-0.23	-0.14	0.76	-0.14	0.17	-0.1	-0.13	-0.12		0.29	-0.28	-0.12	-0.6	-0.91	0.04	0.11	0.68	-0.04	-0.01	0.03	0.64	-0.2	-0.12
Non Currrent Assets Other	0.42	0.7	0.58	0.57	-0.04	0.28	-0.56	0.08	-0.56	0.63	0.45	0.29		0.16	0.65	-0.33	-0.3	0.18	0.71	0.51	0.62	0.58	0.77	0.47	0.38	0.51
Cash And Short Term Investments	0.94	0.2	0.36	0.66	0.84	0.13	0.29	-0.6	0.34	0.47	0.74	-0.28	0.16		0.42	-0.28	0.08	0.62	0.21	-0.14	0.61	0.59	0.36	0.21	0.95	0.58
Net Receivables	0.66	0.21	0.86	0.89	0.45	0.3	0.0	-0.48	-0.27	0.82	0.65	-0.12	0.65	0.42		-0.3	0.11	0.66	0.24	0.28	0.78	0.79	0.45	0.36	0.66	0.74
Good Will	-0.45	-0.22	-0.23	-0.31	-0.31	-0.7	-0.26	0.19	0.08	-0.35	-0.32	-0.6	-0.33	-0.28	-0.3		0.78	-0.47	-0.23	-0.42	-0.32	-0.55	-0.28	-0.49	-0.38	-0.18
Common Stock Total Equity	-0.05	-0.26	0.18	0.14	0.06	-0.75	-0.03	-0.16	0.09	0.04	0.03	-0.91	-0.3	0.08	0.11	0.78		-0.09	-0.25	-0.55	0.0	-0.11	-0.18	-0.61	0.03	0.05
Common Stock Shares Outstanding	0.74	-0.03	0.61	0.71	0.73	0.61	0.49	-0.6	0.04	0.61	0.58	0.04	0.18	0.62	0.66	-0.47	-0.09		-0.01	0.38	0.57	0.8	0.19	0.62	0.73	0.62
Non Current Liabilities Total	0.32	1.0	0.32	0.4	-0.29	0.0	-0.39	0.3	-0.71	0.52	0.42	0.11	0.71	0.21	0.24	-0.23	-0.25	-0.01		0.2	0.35	0.5	0.97	0.31	0.3	0.25
Inventory	0.11	0.19	0.38	0.21	-0.02	0.71	-0.27	0.22	-0.36	0.34	-0.06	0.68	0.51	-0.14	0.28	-0.42	-0.55	0.38	0.2		0.22	0.38	0.23	0.76	0.05	0.21
Other Current Assets	0.77	0.33	0.57	0.85	0.52	0.37	-0.12	-0.63	-0.11	0.77	0.85	-0.04	0.62	0.61	0.78	-0.32	0.0	0.57	0.35	0.22		0.68	0.53	0.44	0.76	0.76
Other Stockholder Equity	0.78	0.48	0.82	0.88	0.44	0.39	0.14	-0.32	-0.41	0.87	0.69	-0.01	0.58	0.59	0.79	-0.55	-0.11	0.8	0.5	0.38	0.68		0.67	0.51	0.77	0.62
Total Liab	0.5	0.96	0.5	0.62	-0.1	0.07	-0.31	0.11	-0.68	0.71	0.58	0.03	0.77	0.36	0.45	-0.28	-0.18	0.19	0.97	0.23	0.53	0.67		0.37	0.48	0.41
Property Plant And Equipment Gross	0.4	0.31	0.25	0.36	0.23	0.88	0.06	-0.18	-0.23	0.4	0.37	0.64	0.47	0.21	0.36	-0.49	-0.61	0.62	0.31	0.76	0.44	0.51	0.37		0.34	0.47
Total Current Assets	1.0	0.28	0.58	0.83	0.82	0.25	0.21	-0.61	0.16	0.67	0.82	-0.2	0.38	0.95	0.66	-0.38	0.03	0.73	0.3	0.05	0.76	0.77	0.48	0.34		0.71
Short Term Debt	0.71	0.24	0.61	0.71	0.54	0.31	-0.02	-0.46	-0.04	0.6	0.65	-0.12	0.51	0.58	0.74	-0.18	0.05	0.62	0.25	0.21	0.76	0.62	0.41	0.47	0.71

Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	84.7M	74.1M	68.7M	51.8M	79.2M	83.2M
Short Long Term Debt Total	1.1M	676K	305K	796K	38.5M	40.4M
Other Current Liab	1.5M	6.3M	9.6M	13.6M	8.8M	9.2M
Total Current Liabilities	12.2M	9.2M	13.2M	11.9M	12.7M	13.4M
Total Stockholder Equity	71.3M	63.7M	53.7M	37.6M	26.7M	24.4M
Property Plant And Equipment Net	7.6M	7.2M	6.9M	7.6M	7.1M	5.3M
Net Debt	(57.7M)	(41.2M)	(30.6M)	(9.4M)	(5.2M)	(5.4M)
Retained Earnings	14.5M	2.6M	(12.6M)	(35.7M)	(54.4M)	(51.7M)
Accounts Payable	2.4M	1.5M	2.6M	2.7M	2.7M	2.8M
Cash	58.8M	41.9M	30.9M	10.2M	43.7M	45.8M
Non Current Assets Total	8.0M	8.0M	8.0M	8.8M	8.9M	8.2M
Non Currrent Assets Other	391K	807K	1.1M	1.2M	1.7M	1.8M
Cash And Short Term Investments	58.8M	41.9M	30.9M	10.2M	43.7M	45.8M
Net Receivables	9.2M	17.3M	21.2M	18.2M	14.1M	14.8M
Common Stock Shares Outstanding	34.1M	34.2M	34.3M	34.5M	34.6M	22.4M
Liabilities And Stockholders Equity	84.7M	74.1M	68.7M	51.8M	79.2M	83.2M
Non Current Liabilities Total	1.2M	1.1M	1.5M	2.1M	39.6M	41.6M
Inventory	5.1M	4.1M	6.8M	11.8M	9.9M	5.3M
Other Current Assets	3.6M	2.8M	1.9M	2.7M	2.7M	2.9M
Other Stockholder Equity	56.7M	61.1M	66.2M	73.3M	81.1M	85.2M
Total Liab	13.4M	10.3M	14.7M	14.0M	52.3M	54.9M
Property Plant And Equipment Gross	7.5M	7.2M	6.9M	7.6M	10.7M	5.4M
Total Current Assets	76.7M	66.1M	60.7M	43.0M	70.4M	73.9M
Other Assets	191K	1.5M	1.1M	1.2M	1.4M	1.1M
Property Plant Equipment	6.6M	7.2M	6.6M	6.8M	7.8M	5.8M
Net Tangible Assets	71.3M	63.7M	53.7M	37.6M	43.2M	40.5M
Retained Earnings Total Equity	14.5M	2.6M	(12.6M)	(35.7M)	(41.1M)	(39.0M)
Capital Surpluse	56.7M	61.1M	66.2M	73.3M	84.3M	51.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Research Development vs Depreciation And Amortization Analysis

Research Development vs Depreciation And Amortization

Research Development vs Depreciation And Amortization Correlation Analysis

Correlation Coefficient

Research Development

Depreciation And Amortization

Apyx Medical fundamental ratios Correlations

Apyx Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Apyx Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for Apyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 0.97	Non Current Liabilities Total
Total Liab	+ 0.96	Short Long Term Debt Total
Accounts Payable	+ 0.95	Total Current Liabilities
Total Current Assets	+ 0.95	Cash And Short Term Investments

Common Stock Total Equity	- 0.91	Non Current Assets Total
Net Debt	- 0.77	Total Stockholder Equity
Common Stock Total Equity	- 0.75	Property Plant And Equipment Net
Cash	- 0.73	Net Debt
Non Current Liabilities Total	- 0.71	Retained Earnings
Good Will	- 0.7	Property Plant And Equipment Net